• More than 20 years of experience from the pharma/biotech industry and more than 15 years of project management • I have a large network of consultants, CROs, and venture capitalists • My focus area is primarily on the preclinical (research; pharmacology, selection of lead, in vitro/in vivo PK/ADME) and nonclinical (NC) drug development, covering pharmacology and PK/ADME/DDI. • Defining the overall IND-enabling NC data package. • Arranging and monitorering of pharmacology and PK/ADME/DDI studies. • Experience with small-molecule based compounds (NCE, peptides, peptide-conjugates) and biopharmaceuticals (biologics, antibodies, and antibody-drug conjugates) • Writing of IB/IND/CTA/eCTD/preIND For the last 12 years, working as independent consultant for small and medium-size biotech companies, I participated in moving 11 drugs from the early preclinical discovery stage into phase 1-3 clinical trials. Prior to working as a freelancer, I worked for biotech companies in permanent positions. Evaluation of proposals, projects and comapnies is also within my expertise area. I previously worked for a venture capitalist, investing in biotech companies, and currently I work as a jury member and evaluator for EIC and at the Innovationsfonden in Denmark.